A detailed history of Northern Oak Wealth Management Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Northern Oak Wealth Management Inc holds 7,775 shares of ABT stock, worth $896,224. This represents 0.1% of its overall portfolio holdings.

Number of Shares
7,775
Previous 7,772 0.04%
Holding current value
$896,224
Previous $807,000 9.79%
% of portfolio
0.1%
Previous 0.1%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$100.07 - $118.13 $300 - $354
3 Added 0.04%
7,775 $886,000
Q2 2024

Jul 26, 2024

SELL
$100.73 - $112.44 $1.61 Million - $1.79 Million
-15,940 Reduced 67.22%
7,772 $807,000
Q1 2024

May 01, 2024

SELL
$109.52 - $120.96 $418,366 - $462,067
-3,820 Reduced 13.87%
23,712 $2.7 Million
Q4 2023

Jan 11, 2024

SELL
$90.19 - $110.4 $15,783 - $19,320
-175 Reduced 0.63%
27,532 $3.03 Million
Q3 2023

Oct 24, 2023

SELL
$95.53 - $114.62 $56,171 - $67,396
-588 Reduced 2.08%
27,707 $2.68 Million
Q2 2023

Jul 31, 2023

SELL
$100.78 - $112.29 $108,338 - $120,711
-1,075 Reduced 3.66%
28,295 $3.08 Million
Q1 2023

May 09, 2023

BUY
$96.86 - $114.01 $1.45 Million - $1.71 Million
14,999 Added 104.37%
29,370 $2.97 Million
Q4 2022

Feb 13, 2023

BUY
$95.06 - $111.52 $9,506 - $11,152
100 Added 0.7%
14,371 $1.58 Million
Q2 2022

Aug 16, 2022

BUY
$102.07 - $123.37 $16,331 - $19,739
160 Added 1.13%
14,271 $1.55 Million
Q1 2022

May 24, 2022

SELL
$114.02 - $139.04 $62,026 - $75,637
-544 Reduced 3.71%
14,111 $1.67 Million
Q4 2021

Feb 16, 2022

BUY
$115.53 - $141.46 $326,256 - $399,483
2,824 Added 23.87%
14,655 $2.06 Million
Q3 2021

Nov 15, 2021

SELL
$116.66 - $129.06 $30,798 - $34,071
-264 Reduced 2.18%
11,831 $1.4 Million
Q2 2021

Aug 17, 2021

SELL
$105.79 - $124.53 $75,322 - $88,665
-712 Reduced 5.56%
12,095 $1.4 Million
Q4 2020

Feb 16, 2021

BUY
$105.0 - $114.42 $3,465 - $3,775
33 Added 0.26%
12,807 $1.4 Million
Q3 2020

Nov 16, 2020

SELL
$91.64 - $111.29 $27,400 - $33,275
-299 Reduced 2.29%
12,774 $1.39 Million
Q2 2020

Aug 17, 2020

BUY
$76.57 - $98.0 $22,894 - $29,302
299 Added 2.34%
13,073 $1.2 Million
Q1 2020

May 15, 2020

BUY
$62.82 - $91.86 $226,466 - $331,155
3,605 Added 39.32%
12,774 $1.01 Million
Q4 2019

Jan 27, 2020

BUY
$78.51 - $87.4 $43,416 - $48,332
553 Added 6.42%
9,169 $796,000
Q2 2019

Jul 30, 2019

SELL
$72.88 - $85.0 $29,152 - $34,000
-400 Reduced 4.44%
8,616 $0
Q1 2019

Apr 24, 2019

SELL
$66.22 - $80.06 $927 - $1,120
-14 Reduced 0.16%
9,016 $0
Q4 2018

Feb 14, 2019

SELL
$65.56 - $74.27 $22,290 - $25,251
-340 Reduced 3.63%
9,030 $653,000
Q3 2018

Nov 15, 2018

SELL
$60.81 - $73.36 $13,986 - $16,872
-230 Reduced 2.4%
9,370 $0
Q2 2018

Aug 13, 2018

SELL
$57.57 - $63.54 $18,710 - $20,650
-325 Reduced 3.27%
9,600 $0
Q1 2018

May 11, 2018

SELL
$56.27 - $63.62 $3.18 Million - $3.59 Million
-56,459 Reduced 85.05%
9,925 $0
Q4 2017

Feb 16, 2018

BUY
$53.68 - $57.47 $109,990 - $117,756
2,049 Added 3.18%
66,384 $0
Q3 2017

Nov 15, 2017

BUY
$48.06 - $53.64 $3.09 Million - $3.45 Million
64,335
64,335 $0

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $202B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Northern Oak Wealth Management Inc Portfolio

Follow Northern Oak Wealth Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Oak Wealth Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Northern Oak Wealth Management Inc with notifications on news.